« Back
Home /
BT-483 cells

BT-483 cells

Manufacturer	Addexbio
Category	Cell Lines & Cell Culture Cell Lines
Type	Tumour Cells
Specific against	Human
Amount	One Frozen vial
Item no.	C0006013
eClass 6.1	32160890
eClass 9.0	32160890
Available
Description	Disease: Ductal Carcinoma Origin: This cell line was isolated from a papillary invasive ductal tumor obtained from a 23 year old, normal, menstruating, parous female patient with family history of breast cancer.. Species: Homo sapiens Tissue: Mammary gland/breast Morphology: Epithelial Properties: Adherent Cytogenic data: modal number = 72; range = 46 to 130 Patient: Female, 23 yrs of age, Caucasian Medium: AddexBio-formulated RPMI-1640 Medium(C0004-01) + 20% FBS + 0.01 mg/mL bovine insulin Subculture: Subculture at 1:2; feed cells 2 to 3 times weekly. Culture at 5% CO2; 37C Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, X CSF1PO: 9, 12 D13S317: 8, 12 D16S539: 11, 12 D5S818: 11 D7S820: 9, 10 THO1: 5, 9.3 TPOX: 8, 11 vWA: 17 Citation Format: If use of this culture results in a scientific publication, it should be cited in the publication as: BT-483 (AddexBio C0006013) Related cells by Organ: 4T1 AU-565 BT-20 BT-474 BT-483 BT-549 JIMT-1 MCF-7 SK-BR-3 T47D ZR-75-1
Storage condition	LN2
Manufacturers Category	Cell Lines

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: One Frozen vial

available

Delivery expected until 5/9/2024